Akoya Biosciences Inc.’s recently made public that its Chief Operating Officer Pla Frederic acquired Company’s shares for reported $92014.0 on Sep 07. In the deal valued at $4.60 per share,20,000 shares were bought. As a result of this transaction, Pla Frederic now holds 20,000 shares worth roughly $ 86800.0.
Then, Raffin Thomas A. bought 2,020,000 shares, generating $10,100,000 in total proceeds. Upon buying the shares at $5.00, the Director now owns 15,937,535 shares.
Before that, Winkler Matthew bought 203,388 shares. Akoya Biosciences Inc. shares valued at $1,016,940 were divested by the Director at a price of $5.00 per share. As a result of the transaction, Winkler Matthew now holds 984,513 shares, worth roughly $4.27 million.
PT values the company’s stock at a premium of 75.89 to its Friday closing price.
Price Performance Review of AKYA
On Friday, Akoya Biosciences Inc. [NASDAQ:AKYA] saw its stock jump 2.12% to $4.34. On the same session, the stock had its day’s lowest price of $4.19, but rose to a high of $4.3781. Over the last five days, the stock has gained 0.70%. Akoya Biosciences Inc. shares have fallen nearly -54.65% since the year began. Nevertheless, the stocks have fallen -66.01% over the past one year. While a 52-week high of $14.38 was reached on 02/17/23, a 52-week low of $4.17 was recorded on 09/14/23. SMA at 50 days reached $5.94, while 200 days put it at $8.22. A total of 0.91 million shares were traded, compared to the trading of 0.16 million shares in the previous session.
Levels Of Support And Resistance For AKYA Stock
The 24-hour chart illustrates a support level at 4.23, which if violated will result in even more drops to 4.11. On the upside, there is a resistance level at 4.42. A further resistance level may holdings at 4.49. The Relative Strength Index (RSI) on the 14-day chart is 31.50, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.47, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 86.92%. Stochastics %K at 8.09% indicates the stock is a buying.
How much short interest is there in Akoya Biosciences Inc.?
A steep rise in short interest was recorded in Akoya Biosciences Inc. stocks on Aug 30, 2023, dropping by 16350.0 shares to a total of 0.67 million shares. Yahoo Finance data shows the prior-month short interest on Jul 30, 2023 was 0.68 million shares. There was a decline of -2.45%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 2.14% of the overall stock float, the days-to-cover ratio (short ratio) fell to 4.73.
According to FactSet, Akoya Biosciences Inc.’s share price will average $14.13 in the next year, based on opinions of analysts polled by the firm. This is up nearly 241.18 percent from its previous closing price of $4.25. Analysts expect Akoya Biosciences Inc. stock to reach the higher price of $16.00, while the lowest price estimate is $11.00. However, 8 analysts have rated AKYA stock as a Buy in their predictions for 2023.